Chemoinformaics analysis of Lysophosphatidylcholine
| Molecular Weight | 299.26 | nRot | 9 |
| Heavy Atom Molecular Weight | 277.084 | nRig | 2 |
| Exact Molecular Weight | 299.113 | nRing | 0 |
| Solubility: LogS | -0.155 | nHRing | 0 |
| Solubility: LogP | -2.736 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 41.7134 |
| nHD | 1 | BPOL | 40.0026 |
| QED | 0.335 |
| Synth | 4.16 |
| Natural Product Likeliness | 1.211 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.012 |
| HIA | 0.263 |
| CACO-2 | -5.939 |
| MDCK | 0.00031593 |
| BBB | 0.201 |
| PPB | 0.101879 |
| VDSS | 0.432 |
| FU | 0.962404 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.254 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.044 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.305 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.623 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.07 |
| CL | 1.703 |
| T12 | 0.953 |
| hERG | 0.028 |
| Ames | 0.155 |
| ROA | 0.086 |
| SkinSen | 0.347 |
| Carcinogencity | 0.741 |
| EI | 0.038 |
| Respiratory | 0.132 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.731649 |